Cercar

17/12/2021 Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases
Paloschi, V, Sabater-Lleal, M, Middelkamp, H, Vivas, A, Johansson, S, van der Meer, A, Tenje, M, Maegdefessel, L. Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases. CARDIOVASCULAR RESEARCH. 2021; 117(14)DOI:10.1093/cvr/cvab088. PMID:33729461. IF:14.239(Q1/1D).
01/11/2021 Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma
Bastos-Oreiro, M, Ortiz, J, Pradillo, V, Salas, E, Marinez-Laperche, C, Munoz, A, Buno, I, Diez-Martin, JL, Soria, JM, Izquierdo, CP. Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma. Cancer Medicine. 2021; 10(21)DOI:10.1002/cam4.4280. PMID:34598309. IF:4.711(Q2/5D).
01/10/2021 Prevalence and predisposition to deep vein thrombosis in professional male soccer players
Drobnic, F, de Suso, JMG, Turmo-Garuz, A, Gudelis, M, Valle, X, Peirau, X, Souto, JC, Escudero, JR, Soria, JM. Prevalence and predisposition to deep vein thrombosis in professional male soccer players. Apunts Sports Medicine. 2021; 56(212)DOI:10.1016/j.apunsm.2021.100364. PMID:. IF:(Q/D).
01/09/2021 Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study
Ellervik, C, Mora, S, Kus, A, Asvold, B, Marouli, E, Deloukas, P, Sterenborg, RBTM, Teumer, A, Burgess, S, Sabater-Lleal, M, Huffman, J, Johnson, AD, Tregouet, DA, Smith, NL, Medici, M, DeVries, PS, Chasman, DI, Kjaergaard, AD. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study. THYROID. 2021; 31(9)DOI:10.1089/thy.2021.0055. PMID:34210154. IF:6.506(Q1/2D).
01/08/2021 Preoperative geriatric assessment , a promising tool to improve outcomes in aortic pathology interventions
Sanchez-Garcia, L, Fite, J, Peypoch, O, Moreno, J, Jubert, Q, Carricas, BS, Dilme, JF, Escudero, JR. Preoperative geriatric assessment , a promising tool to improve outcomes in aortic pathology interventions. INTERNATIONAL ANGIOLOGY. 2021; 40(4)DOI:10.23736/S0392-9590.21.04643-5. PMID:33913311. IF:2.103(Q4/8D).
01/08/2021 FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer
Thibord, F, Song, C, Pattee, J, Rodriguez, BAT, Chen, MH, O'Donnell, CJ, Kleber, ME, Delgado, GE, Guo, XQ, Yao, J, Taylor, KD, Ozel, AB, Brody, JA, McKnight, B, Gyorgy, B, Simonsick, E, Leonard, HL, Carrasquilla, GD, Guindo-Martinez, M, Silveira, A, Temprano-Sagrera, G, Yanek, LR, Becker, DM, Mathias, RA, Becker, LC, Raffield, LM, Kilpelainen, TO, Grarup, N, Pedersen, O, Hansen, T, Linneberg, A, Hamsten, A, Watkins, H, Sabater-Lleal, M, Nalls, MA, Tregouet, DA, Morange, PE, Psaty, BM, Tracy, RP, Smith, NL, Desch, KC, Cushman, M, Rotter, JI, de Vries, PS, Pankratz, ND, Folsom, AR, Morrison, AC, Marz, W, Tang, WH, Johnson, AD. FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2021; 19(8)DOI:10.1111/jth.15345. PMID:33876560. IF:16.041(Q1/1D).